MedTrace Logo

FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

NCT00293670 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 573

Last updated 2006-02-17

No results posted yet for this study

Summary

To compare intermittent androgen deprivation (LHRHa treatment) with continuous androgen deprivation (LHRHa treatment or orchidectomy)

Conditions

  • Patients With T1-4 Advanced Prostate Cancer

Interventions

DRUG

Goserelin (Zoladex)

Sponsors & Collaborators

  • Finnish Prostate Cancer Group

    collaborator UNKNOWN

  • Tampere University

    lead OTHER

Principal Investigators

  • Teuvo L Tammela, Professor · Tampere University Central Hospital, Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-05-31
Completion
2015-04-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00293670 on ClinicalTrials.gov